These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 6947720)
61. [Reactivity of monoclonal antibodies in cytotoxicity and immunofluorescence tests]. Koubek K Cas Lek Cesk; 1982 Nov; 121(44):1359-63. PubMed ID: 6756637 [No Abstract] [Full Text] [Related]
62. Monoclonal antibodies as enhancers of the host's immunoresponse against the tumour. Mellstedt H Ann Oncol; 2000; 11 Suppl 3():191-4. PubMed ID: 11079140 [No Abstract] [Full Text] [Related]
63. [Immunologic manifestations in the serum of patients with malignant diseases]. Konopík J; Chaloupecká P; Kohout P; Jakoubková J; Lintner L Cesk Dermatol; 1975 Jun; 50(3):169-73. PubMed ID: 1139664 [No Abstract] [Full Text] [Related]
64. Liposomes as aids to tumour detection. Barratt GM; Ryman BE; Chester KA; Begent RH Biochem Soc Trans; 1984 Apr; 12(2):348-9. PubMed ID: 6724123 [No Abstract] [Full Text] [Related]
65. Antibodies against osteosarcoma and colon cancer. Embleton MJ; Brown A; Gunn B; Byers VS; Baldwin RW Behring Inst Mitt; 1984 May; (74):35-8. PubMed ID: 6591916 [TBL] [Abstract][Full Text] [Related]
66. Isolation of isotype variants from hybridomas producing monoclonal antibodies to urothelial cancer associated antigens. Lovric J; Decken K; Ebert T; Schmitz-Dräger BJ Investig Urol (Berl); 1994; 5():71-5. PubMed ID: 7719324 [No Abstract] [Full Text] [Related]
68. Production of anti-tumor human monoclonal antibodies using different approaches. Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684 [TBL] [Abstract][Full Text] [Related]
69. Engineering mouse monoclonal antibodies for cancer immunotherapy. Orlandi R Year Immunol; 1993; 7():69-73. PubMed ID: 8372514 [No Abstract] [Full Text] [Related]